The Development of West Nile Virus Safety Policies by Canadian Blood Services: Guiding Principles and a Comparison Between Canada and the United States

References 

1. Centers for Disease Control and Prevention . Outbreak of West Nile viral encephalitis—New York, 1999. Morb. Mortal. Wkly. Rep. 1999;48:845–849
2. Centers for Disease Control and Prevention . Provisional surveillance summary of the West Nile virus epidemic—United States, January-November 2002. Morb. Mortal. Wkly. Rep. 2002;51:1129–1133
3. Public Health Agency of Canada . West Nile Virus surveillance, education, prevention, and response. www.phac-aspc.gc.ca/wn-no/surveillance_e.html
4. Biggerstaff BJ, Petersen LR. Estimated risk of West Nile Virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion. 2002;42:1019–1026
5. Centers for Disease Control and Prevention . Update: investigations of West Nile virus infection in recipients of organ transplantation and blood transfusion. Morb. Mortal. Wkly. Rep. 2002;51:833–836
6. Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N. Engl. J. Med. 2003;348:2196–2203
   • CrossRef
7. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N. Engl. J. Med. 2003;349:1236–1245
   • CrossRef
8. Stramer SL, Beyers ML, Wagner AG, et al. West Nile virus (WNV) RNA prevalence in blood donations during the 2002 US epidemic. Transfusion. 2003;43:3A;(Suppl)
9. Biggerstaff BJ, Petersen LR. Estimated risk of transmission of the West Nile virus through blood transfusion in the US in 2002. Transfusion. 2003;43:1007–1017
10. Hume HA, Hannach B, Lau W, et al. Transfusion-transmitted (TT) West Nile virus (WNV) in Canada in 2002. Transfusion. 2003;43:127A;(Suppl)
11. Food and Drug Administration , Center for Biologics Evaluation and Research . Workshop on development of donor screening assays for West Nile virus. November 4-5, 2002. http://www.fda.gov/cber/meetings/wnv110402.htm
12. American Association of Blood Banks, America's Blood Centers, and American Red Cross. Joint statement: voluntary withdrawal of frozen blood products to mitigate risk of transmission of WNV. December 12, 2002
13. Tobler LH, Bianco C, Glynn SA. Detection of WNV RNA in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic. Transfusion. 2005;45:480–486
14. Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for industry: revised recommendations for the assessment of donor suitability and blood and blood product safety in cases of known or suspected West Nile virus infection (final guidance). May 1, 2003
15. Centers for Disease Control and Prevention . Detection of West Nile virus in blood donations—United States, 2003. Morb. Mortal. Wkly. Rep. 2004;52:769–772
16. Busch MP, Tobler LH, Saldanha J, et al. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003. Transfusion. 2005;45:492–499
17. Stramer SL, Fang CT, Foster GF, et al. West Nile virus in United States blood donors, 2003 and 2004. N. Engl. J. Med. 2005;353:451–459
    • CrossRef
18. Public Health Agency of Canada . West Nile virus monitor. Surveillance data. www.phac-aspc.gc.ca/wnv-vwn/index/html
19. Busch MP, Caglioti S, Robertson GF, et al. Screening the blood supply for West Nile virus RNA by Nucleic Acid Amplification Testing. N. Engl. J. Med. 2005;353:460–467
    • CrossRef
20. Cameron C, Reeves J, Antonishyn N, et al. West Nile virus in Canadian blood donors. Transfusion. 2005;45:487–491
21. Centers for Disease Control and Prevention . Update: West Nile virus screening of blood donations and transfusion-associated transmission—United States, 2003. Morb. Mortal. Wkly. Rep. 2004;53:281–284
22. Custer B, Tomasulo P, Murphy EL, et al. Triggers for switching from minipool testing by nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Transfusion. 2004;44:1547–1554
23. American Association of Blood Banks (AABB) . Update on WNV-related activities and considerations, 2004: a summary of the WNV Task Force meeting. Bulletin #04-3 (April 15, 2004) www.aabb.org
24. Petersen LR, Epstein JS. Problem solved? West Nile virus and transfusion safety. N. Engl. J. Med. 2005;353:516–517
    • CrossRef
25. Petersen LR, Hayes EB. Westward ho?—the spread of West Nile virus. N. Engl. J. Med. 2004;351:2257–2259
    • CrossRef
26. Krever H. Commission of Inquiry on the Blood System in Canada. Final report. Ottawa, Canada: Canadian Government Publishing; 1997;
27. Dodd RY. Emerging infections, transfusion safety, and epidemiology. N. Engl. J. Med. 2003;349:1205–1206
    • CrossRef
28. Kleinman S, Glynn SA, Busch M, et al. The 2003 West Nile virus US epidemic: the America's Blood Centers experience. Transfusion. 2005;45:469–479